LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged invalid · clear

Federal Circuit

Semicolons Strongly Indicate Each Step is Separate and Distinct; Confuse Most Non-Patent Lawyers

In In re Affinity Labs of Texas, LLC, [2016-1173] (May 5, 2017), the Federal Circuit affirmed the Board’s decision that §317(b) did not bar the reexamination and that the reexamined claims were invalid. Affinity sued Apple for infringement of…

May 11, 2017·Federal Circuit·2 min read
Trademark

Microsoft v. i4i: Would USSC Unsettle the Settled Law OR Set New Standards?

Microsoft Corporation, one of the largest software companies of the world, has posed an even larger question before the U.S. Supreme Court pertaining to Patent law. Patent law has been brought to an edge now, pending decision of the Supreme Court in the…

March 8, 2011·Trademark·5 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.